- Home
- AQB vs TTNP Comparison
AQB vs TTNP Comparison
Compare AQB & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQB
- TTNP
- Stock Information
- Founded
- AQB 1991
- TTNP 1991
- Country
- AQB United States
- TTNP United States
- Employees
- AQB N/A
- TTNP N/A
- Industry
- AQB
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AQB
- TTNP Health Care
- Exchange
- AQB Nasdaq
- TTNP Nasdaq
- Market Cap
- AQB 3.4M
- TTNP 3.3M
- IPO Year
- AQB N/A
- TTNP 1996
- Fundamental
- Price
- AQB $0.58
- TTNP $3.24
- Analyst Decision
- AQB Hold
- TTNP
- Analyst Count
- AQB 2
- TTNP 0
- Target Price
- AQB N/A
- TTNP N/A
- AVG Volume (30 Days)
- AQB 838.2K
- TTNP 34.6K
- Earning Date
- AQB 11-05-2024
- TTNP 01-03-2025
- Dividend Yield
- AQB N/A
- TTNP N/A
- EPS Growth
- AQB N/A
- TTNP N/A
- EPS
- AQB N/A
- TTNP N/A
- Revenue
- AQB $1,258,512.00
- TTNP $3,000.00
- Revenue This Year
- AQB N/A
- TTNP N/A
- Revenue Next Year
- AQB $57.38
- TTNP N/A
- P/E Ratio
- AQB N/A
- TTNP N/A
- Revenue Growth
- AQB N/A
- TTNP N/A
- 52 Week Low
- AQB $0.47
- TTNP $3.14
- 52 Week High
- AQB $3.00
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- AQB 30.45
- TTNP 36.41
- Support Level
- AQB $0.47
- TTNP $3.25
- Resistance Level
- AQB $1.00
- TTNP $3.85
- Average True Range (ATR)
- AQB 0.14
- TTNP 0.39
- MACD
- AQB -0.02
- TTNP -0.01
- Stochastic Oscillator
- AQB 21.18
- TTNP 8.84
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.